Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China
- PMID: 35834269
- PMCID: PMC9284409
- DOI: 10.1001/jamaoncol.2022.2810
Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China
Abstract
Importance: Microbiota-tumor interactions have qualified microbiota as a promising prognostic biomarker in various types of cancers. Although the nasopharynx acts as a crucial niche of the upper respiratory tract microbiome, whether the intratumoral microbiota exists and its clinical significance in nasopharyngeal carcinoma (NPC) remain uncertain.
Objective: To evaluate the clinical significance of intratumoral microbiota for individual prognostication in patients with NPC.
Design, setting, and participants: This retrospective cohort study included NPC biopsy samples from 2 hospitals: Sun Yat-sen University Cancer Center (Guangzhou, China) and Zhejiang Cancer Hospital (Hangzhou, China) between January 2004 and November 2016, with follow-up through November 2020. A total of 802 patients were included according to the following criteria: with histologically proven NPC, without distant metastasis at initial diagnosis, had not received antitumor treatment before biopsy sampling, aged between 18 and 70 years, with complete medical records and regular follow-up, without a history of cancer, and successfully extracted enough DNA for experiments.
Main outcomes and measures: The primary end point was disease-free survival, and the secondary end points included distant metastasis-free survival and overall survival. To assess the existence and load of intratumoral microbiota in 96 patients with NPC with or without tumor relapse, 16S rRNA sequencing and quantitative polymerase chain reaction were used. The associations between intratumoral bacterial load and clinical outcome were evaluated in 241 fresh-frozen NPC samples (training cohort) and validated in paraffin-embedded NPC samples of internal (n = 233) and external (n = 232) validation cohorts. Metagenomic and transcriptome analyses were performed to ascertain the origin and underlying mechanism of intratumoral bacteria.
Results: A total of 802 patients with NPC (mean [SD] age, 46.2 [10.6] years; 594 [74.1%] male) were enrolled. Microbiota presented within NPC tumor tissues, among which Corynebacterium and Staphylococcus predominated. Patients with a high bacterial load in the training cohort had inferior rates of disease-free survival (hazard ratio [HR], 2.90; 95% CI, 1.72-4.90; P < .001), distant metastasis-free survival (HR, 3.18; 95% CI, 1.58-6.39; P < .001), and overall survival (HR, 3.41; 95% CI, 1.90-6.11, P < .001) than those with a low bacterial load, a finding that was validated by the internal and external validation cohorts. Single-nucleotide variant analysis revealed that the nasopharyngeal microbiota was the main origin of NPC intratumoral bacteria. Transcriptome and digital pathology analyses demonstrated that a higher intratumoral bacterial load was negatively associated with T-lymphocyte infiltration.
Conclusions and relevance: Intratumoral bacterial load was a robust prognostic tool for patients with NPC in this cohort study, indicating potential guidance for treatment decisions in patients at different levels of risk of malignant progression.
Conflict of interest statement
Figures




Similar articles
-
Tissue-resident microbiota signature in nasopharyngeal carcinoma.Microbiome. 2025 May 17;13(1):125. doi: 10.1186/s40168-025-02114-w. Microbiome. 2025. PMID: 40382629 Free PMC article.
-
Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.Lancet Oncol. 2018 Mar;19(3):382-393. doi: 10.1016/S1470-2045(18)30080-9. Epub 2018 Feb 7. Lancet Oncol. 2018. PMID: 29428165
-
Synergistic Association of Hepatitis B Surface Antigen and Plasma Epstein-Barr Virus DNA Load on Distant Metastasis in Patients With Nasopharyngeal Carcinoma.JAMA Netw Open. 2023 Feb 1;6(2):e2253832. doi: 10.1001/jamanetworkopen.2022.53832. JAMA Netw Open. 2023. PMID: 36757699 Free PMC article.
-
The role of microbiota in nasopharyngeal cancer: Where do we stand?Oral Oncol. 2024 Nov;158:106982. doi: 10.1016/j.oraloncology.2024.106982. Epub 2024 Aug 16. Oral Oncol. 2024. PMID: 39153457 Review.
-
Minimally Invasive Surgery for Early-Stage Nasopharyngeal Carcinoma.J Craniofac Surg. 2022 Nov-Dec 01;33(8):e834-e837. doi: 10.1097/SCS.0000000000008765. Epub 2022 Jul 26. J Craniofac Surg. 2022. PMID: 35882244 Free PMC article. Review.
Cited by
-
Microbes translocation from oral cavity to nasopharyngeal carcinoma in patients.Nat Commun. 2024 Feb 22;15(1):1645. doi: 10.1038/s41467-024-45518-2. Nat Commun. 2024. PMID: 38388556 Free PMC article.
-
Intratumoral microbiota: implications for cancer onset, progression, and therapy.Front Immunol. 2024 Jan 16;14:1301506. doi: 10.3389/fimmu.2023.1301506. eCollection 2023. Front Immunol. 2024. PMID: 38292482 Free PMC article. Review.
-
Potential role of intratumor bacteria outside the gastrointestinal tract: More than passengers.Cancer Med. 2023 Aug;12(16):16756-16773. doi: 10.1002/cam4.6298. Epub 2023 Jun 28. Cancer Med. 2023. PMID: 37377377 Free PMC article. Review.
-
Identification of intratumor bacteria-associated prognostic risk score in adrenocortical carcinoma.Microbiol Spectr. 2024 Apr 2;12(4):e0372723. doi: 10.1128/spectrum.03727-23. Epub 2024 Feb 29. Microbiol Spectr. 2024. PMID: 38421176 Free PMC article.
-
CDCP1 promotes the malignant phenotypes of nasopharyngeal carcinoma via the Wnt/β-catenin signaling pathway.BMC Biotechnol. 2025 Jul 7;25(1):67. doi: 10.1186/s12896-025-01001-4. BMC Biotechnol. 2025. PMID: 40624715 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases